News AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 12:35:24 2026-03-10 pm EDT			5-day change	1st Jan Change
14,654.00 ^GBX	+1.47%		-1.86%	+6.27%

10:18pm	Lepu Biopharma Says AstraZeneca Begins Phase 3 Trial of CMG901 Cancer Therapy; Shares Jump 7%	MT
Mar. 10	Keymed Biosciences updates on collaboration with AstraZeneca on core product CMG901 (AZD0901)	RE

All News

10:18pm	Lepu Biopharma Says AstraZeneca Begins Phase 3 Trial of CMG901 Cancer Therapy; Shares Jump 7%	MT
Mar. 10	AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer	BU
Mar. 10	AstraZeneca : PSP share plan rules - for shareholder approval at 2026 AGM	PU
Mar. 10	AstraZeneca : Notice of AGM (Notice of Meeting 2026)	PU
Mar. 10	Keymed Biosciences updates on collaboration with AstraZeneca on core product CMG901 (AZD0901)	RE
Mar. 10	Nordic Stocks in North America - Ericsson Rises 1.3 Percent	FW
Mar. 09	AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu	CI
Mar. 09	Alexion And AstraZeneca Announce Koselugo Approval in Canada for Plexiform Neurofibromas in Adults with Neurofibromatosis Type 1	CI
Mar. 09	UK Shares Start Week in Red as Oil Prices Surge Amid US-Iran War	MT
Mar. 09	Global drugmakers rush to boost US presence as tariff threat looms	RE
Mar. 09	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
Mar. 09	Koselugo approved in Canada for plexiform neurofibromas in adults with neurofibromatosis type 1	AQ
Mar. 09	ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer	BU
Mar. 09	Roche shares drop as oral breast cancer drug combination fails key trial	RE
Mar. 09	Astra drug wins US review as oil surges above USD100	AN
Mar. 09	AstraZeneca, Daiichi Sankyo Wins Priority Review for Enhertu for Breast Cancer	MT
Mar. 09	Daiichi Sankyo says Enhertu gets U.S. Priority Review for HER2-positive early breast cancer	RE
Mar. 09	AstraZeneca and Daiichi secure US fast-track status for cancer drug	AN
Mar. 09	AstraZeneca, Daiichi Sankyo's Enhertu Receives US FDA Priority Review Status in Early Breast Cancer	MT
Mar. 09	AstraZeneca Price Target Up as AlphaValue/Baader Europe Notes Pipeline Strength, FY25 Results	MT
Mar. 09	AstraZeneca : Enhertu granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer	PU
Mar. 09	Daiichi Sankyo And AstraZeneca Announce Acceptance And Priority Review Of Supplemental Biologics License Application For ENHERTU For HER2 Positive Breast Cancer	CI
Mar. 06	AstraZeneca: Strengths remain aptly valued
Mar. 06	Top pharma companies racing to launch a weight-loss pill	RE
Mar. 06	Fda says oncologic drugs advisory committee meeting for camizestrant, truqap sNDA to be held on April 30	RE